|
|
CoreLab Partners are actively engaged in exciting drug development news and leading industry events. Our experts are key opinion leaders in their respective areas, frequently providing commentary for industry publications and facilitating discussions at key events.
Check this section regularly to read the latest CoreLab news and find out where you can meet with CoreLab Partner staff.
Princeton, NJ January 17, 2012 – Signaling a further commitment to expand its business model in the Pacific Rim and building a global presence as one of the largest imaging and cardiac safety core labs in the world,CoreLab Partners, Inc., today has announced the opening of an office in Tokyo, Japan under the wholly owned subsidiary of CoreLab Partners Japan, K.K.
Princeton, NJ October 24, 2011 – CoreLab Partners, Inc. has launched a new semi automated ECG solution through its ongoing collaboration with Analyzing Medical Parameters for Solutions (A.M.P.S.) LLC.
“We are pleased to announce the release of our new semi-automated CalECG v3 solution for the analysis of ECGs” said CoreLab Partners’ President and Chief Executive Officer, Dr. Mike Woehler. “This new application represents our commitment to advancing technologies in the cardiac safety market sector and complements our established processes in our proprietary WebHeart® technology platform” added Woehler.
Princeton, NJ June 17, 2011 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, will showcase several new technological solutions to coincide with the upcoming DIA meeting in Chicago, Illinois to be held from June 20 - 23, 2011.
Princeton, NJ March 25, 2011 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, is set to attend and actively participate in several upcoming industry events around the world over the next two weeks.
Princeton, NJ January 10, 2011 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine.®
Princeton, NJ October 15, 2010 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm Inc. and Medifacts International in February of this year, has launched a full suite of imaging service solutions and quality assurance processes as it relates to Dual Energy X-Ray Absorptiometry (DXA).
Princeton, NJ USA October 6, 2010 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm and Medifacts International in February of this year, has recently completed the first ever regulatory mandated Thorough QT (TQT) study conducted in the Asia Pacific Rim and the first TQT study for a Japanese new drug application (NDA).
CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, will chair key sessions during leading industry conferences in May. Boaz Mendzelevski, MD, Vice President of Cardiology, CoreLab Partners, will Chair the programs of the MACTO Cardiovascular Safety Workshop and the 1st DIA Cardiac Safety Workshop in Japan. Additionally, Dr. Mendzelevski will Chair a stream during the Exploratory Clinical Development World – Europe 2010 Conference.
CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.
RadPharm, Inc. a leading Imaging Core Laboratory and Medifacts International, Inc, a leading Cardiovascular Core Laboratory today announced the merger of their business operations. The combined company will be named CoreLab Partners (“CoreLabs”) and will have its corporate headquarters in Princeton, New Jersey.
Core laboratories Rad-Pharm and Medifacts International recently merged business operations, hoping to attract new clients with their combined portfolios.
See a pdf of the original publication here.
RadPharm Inc, a global provider of centralized medical image management services to the Biopharmaceutical and medical device industries, was recognized as the third-ranked company among the fifty nominated as one of "New Jersey’s Finest” in 2009.
MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiovascular diagnostic services, today announced that they have achieved a company milestone with 10,000 clinical trial sites spread across five continents currently under management.
RadPharm Inc., a global imaging core lab with extensive experience in Oncology drug development, is pleased to pledge its continued support for the Susan G. Komen Race for The Cure.
RadPharm Inc, a global provider of centralized medical image management services to the bio-pharmaceutical and medical device industries announced today that two key executives will be presenting during the upcoming 4th Phacilitate Oncology Leaders Forum 2009 to be held November 9-11, 2009, in Boston, MA. The conference, to be co-located with the Phacilitate 14th R&D Leaders Forum 2009, brings together senior level R&D and business development executives driving the development and launch of novel cancer therapeutics of all classes.
MEDIFACTS INTERNATIONAL, INC., a leading global cardiovascular core lab, announced today that they have completed the integration of SpaceLabs (CTS), forming the largest supplier of Ambulatory Blood Pressure Monitoring (ABPM) in the world. The completed integration of Medifacts International and CTS brings to the clinical trials market a combined company rich with technological and clinical process expertise, something that has been a hallmark of each.
MEDIFACTS INTERNATIONAL, INC. a leading global cardiovascular core lab today announced the successful completion of a Japanese study utilizing Medifacts industry-leading cardiac safety platform WebHeart®.
RadPharm Inc., is pleased to announce the publication of an abstract and the release of two abstracts to be presented during oral presentations at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held in Orlando, FL from May 30-June 1, 2009.
RadPharm Inc, a leading global provider of centralized medical imaging review services to biotechnology, pharmaceutical and medical device organizations is pleased to announce that their Founder and Chief Medical Officer, Robert Ford, M.D, is a contributing author to five articles which were included in the special RECIST 1.1 issue of the European Journal of Cancer.
RadPharm Inc, a leading Imaging CRO, has announced the appointment of Steven F. Owens to the position of Chief Information Officer. In this newly created role, Mr. Owens will serve on the executive committee and provide leadership to IT and development projects that enhance technical capabilities and strengthen business processes critical to delivering outstanding service to RadPharm clients.
|